BHFAO - Brighthouse Financ... Stock Analysis | Stock Taper
Logo
Brighthouse Financial, Inc.

BHFAO

Brighthouse Financial, Inc. NASDAQ
$17.22 0.88% (+0.15)

Market Cap $976.13 M
52w High $22.54
52w Low $14.19
Dividend Yield 10.73%
Frequency Quarterly
P/E 1.37
Volume 91.25K
Outstanding Shares 57.18M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $1.56B $709M $137M 8.8% $1.96 $188M
Q3-2025 $1.71B $287M $479M 28.04% $7.93 $623M
Q2-2025 $790M $401M $85M 10.76% $1.05 $131M
Q1-2025 $2.32B $423M $-268M -11.55% $-5.04 $-316M
Q4-2024 $1.08B $351M $671M 62.3% $11.02 $872M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $5.39B $240.74B $233.91B $6.77B
Q3-2025 $6.61B $243.7B $237.27B $6.36B
Q2-2025 $5.54B $241.56B $235.82B $5.67B
Q1-2025 $4.67B $233.77B $228.46B $5.24B
Q4-2024 $5.04B $239.27B $234.24B $4.96B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $433M $-364M $-1.88B $640M $-1.61B $-364M
Q3-2025 $-268M $117M $1.37B $-423M $1.07B $117M
Q2-2025 $268M $-1M $112M $762M $873M $-1M
Q1-2025 $-268M $146M $563M $-1.09B $-378M $146M
Q4-2024 $0 $-118M $-357M $-110M $-585M $-118M

Revenue by Products

Product Q2-2024Q3-2024Q1-2025Q2-2025
Accident and Health Insurance Product Line
Accident and Health Insurance Product Line
$0 $0 $0 $10.00M
Investment Product
Investment Product
$0 $0 $590.00M $580.00M
Life Insurance Product Line
Life Insurance Product Line
$0 $0 $280.00M $280.00M
Variable Annuity
Variable Annuity
$0 $10.00M $0 $0

Q2 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Brighthouse Financial, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Brighthouse combines solid economic fundamentals with a focused strategic niche. It generates strong gross profitability from its insurance and annuity products, maintains a very liquid balance sheet with more cash than debt, and benefits from a large, diversified investment portfolio. Its earnings per share are healthy, and there is no meaningful dilution. Competitively, it holds recognized positions in structured annuities and hybrid life products, supported by a broad advisor‑driven distribution network and growing digital tools that make it easier for intermediaries to use its solutions. The innovation pipeline, while not captured in classic R&D figures, is active in product design and digital platforms, which can reinforce its market position over time.

! Risks

Key risks center on cash generation, cost structure, and the inherent volatility of the insurance business. Operating and free cash flows are currently negative despite positive net income, raising questions about the quality and sustainability of earnings if this pattern persists. High operating and interest expenses compress margins and could become more burdensome if growth slows or markets turn adverse. Negative retained earnings signal past losses or heavy capital returns that have not yet been fully offset by current profitability. Structurally, the company operates with significant leverage relative to equity, as is common in insurance, and is exposed to interest rate swings, market volatility, regulatory changes, and intense competition in retirement and protection products.

Outlook

The forward picture for Brighthouse is balanced. On one hand, it has the ingredients for resilience: strong gross margins, ample liquidity, conservative net debt, and differentiated products backed by a robust distribution network and ongoing digital investment. On the other hand, the current cash flow shortfall and modest net margins highlight the need for better conversion of accounting profits into cash and tighter cost control. Future performance will likely depend on management’s ability to keep innovating in annuities and hybrid products, deepen digital engagement with advisors, and maintain disciplined capital and risk management. With only one year of detailed financial data in view, any outlook should be considered tentative and subject to revision as more evidence on trends in profitability and cash generation emerges.